🇺🇸

US SEC Filing Intelligence

· daily

High-Value Federal Grants ($5M+) — August 13, 2026

The three contracts analyzed total $860.4 million in obligations, with a heavily civilian tilt (two of three awards from civilian agencies, representing 84% of total value) and only one defense-related award. The dominant theme is stable, mandated civilian spending: the $639.6 million Department of Education grant to Missouri Higher Education Loan Authority is a large but low-signal modification, while the $84.6 million VA medical exam contract to Leidos subsidiary QTC Medical Services reflects statutory demand under the Veterans Benefits Improvement Act. The highest-conviction signal is Booz Allen Hamilton’s $136.2 million competitive win at Tinker AFB, a defense-adjacent IT services award under full-and-open competition that provides a stable ~$25 million annual revenue stream through January 2026. Key risk: the Booz Allen contract is time-and-materials, carrying medium pricing risk, and the QTC contract is nearly fully outlayed, offering no future revenue visibility. No bullish or bearish signals were identified across the set; all three contracts are rated neutral.

3 total filings
· daily

General Federal Contracts — August 13, 2026

The three contracts analyzed total $860.4 million in obligations, with a clear civilian tilt: only one of three contracts is defense-adjacent (Booz Allen Hamilton's $136.2M GSA award at Tinker AFB), while the largest award—$639.6M to the Missouri Higher Education Loan Authority from the Department of Education—is purely civilian and non-defense. The dominant agency theme is civilian services (Education and VA), with the VA's $84.6M medical exam contract to Leidos subsidiary QTC Medical Services representing a fully executed, firm-fixed-price award that provides no forward revenue visibility. The highest-conviction signal is the Booz Allen Hamilton win, which, despite being a neutral signal, demonstrates competitive positioning in defense-adjacent IT services under full-and-open competition. Key risk: the Missouri Higher Education Loan Authority contract lacks pricing, competition, and sector detail, making its materiality opaque and potentially masking execution or budget risk.

3 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 13, 2026

The August 13, 2026 filings for the S&P 500 Technology sector reveal a mixed picture: while Applied Materials posted solid revenue and EPS growth, its operating margin contracted 150 bps due to higher R&D spending, signaling a sector-wide trade-off between growth and profitability. Insider activity is dominated by pre-planned sales and routine option exercises, with the most notable being KLA Corp's CFO selling $6.61M in stock under a 10b5-1 plan, which may raise caution. Fortinet's uniform director RSU grants suggest a standard compensation refresh with no immediate signal. Intuit's multiple executives exercised options and sold shares for tax withholding, a common pattern. The key portfolio-level theme is the tension between investing for future growth (AI, next-gen chips) and protecting margins, with no major guidance changes or M&A disclosed. The lack of forward guidance from Applied Materials adds near-term uncertainty, but strong cash flows and capital returns remain a positive.

14 high priority 1 medium 15 total filings
· daily

Nasdaq 100 Stocks SEC Filings — August 13, 2026

The August 13, 2026, filing batch for the NASDAQ-100 is dominated by a wave of insider selling, with 7 of 10 filings reporting significant disposals by top executives, including the CEO of CoreWeave and the CFO of Booking Holdings, signaling potential caution at the top. The only operational filing, from Applied Materials, reveals a mixed picture: solid 5% YoY revenue growth and an EPS beat are overshadowed by a 150 bps operating margin compression due to aggressive R&D investment, a theme likely to echo across the semiconductor sector. Meanwhile, multiple Intuit executives exercised stock options, a routine but neutral event that highlights the company's ongoing equity compensation structure. The overarching theme is one of capital returns and insider profit-taking against a backdrop of rising investment costs, suggesting that while top-line growth remains intact, margin discipline is a growing concern for investors.

9 high priority 1 medium 10 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — August 13, 2026

This digest of 50 Schedule 13G/D filings reveals a dominant theme of passive institutional accumulation, with Vanguard, BlackRock, and other index/quant funds increasing stakes in several mid- and large-cap names, including Tri Pointe Homes (+0.4% YoY to 10.2%), AAON (+1.5M shares), and NNN REIT (+4.9% share count). However, a notable bearish undercurrent exists: BlackRock trimmed its Lantheus Holdings stake (-0.3% to 5.6%), The Baupost Group reduced Radware holdings (-1.0pp to 5.1%), and Vanguard slightly decreased its Charter Communications position (-0.2pp to 5.9%). The most actionable development is the potential sale of Ardagh Metal Packaging (76% holder preparing for a sale), which could unlock significant value. Activist-adjacent signals are mixed: Saba Capital increased stakes in two closed-end funds (Blackstone Strategic Credit 2027 Term Fund to 7.8%, PIMCO Dynamic Income Strategy Fund to 7.7%) while declaring passive intent, creating a potential catalyst for fund restructuring. Insider activity is limited, but the Ardagh Holdings 13D filing signals a major corporate event. The SPAC sector shows continued passive interest from Magnetar Financial (three new 13G filings) and Mizuho (multiple SPACs), but with minimal conviction as Mizuho exited two SPACs entirely (0% stakes). Overall, the data suggests a market characterized by steady passive flows but selective institutional trimming, with the most alpha potential in event-driven situations like Ardagh Metal Packaging and Saba's CEF positions.

2 high priority 48 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — August 13, 2026

The 13 filings in this S&P 500 Financials stream reveal a sector in transition, with significant insider selling at AIG and Robinhood Ventures Fund I, contrasted by notable insider buying at Berkshire Hathaway. Period-over-period data is limited, but the 13F filings show substantial institutional positioning, with Morgan Stanley's massive portfolio and Allstate's fixed-income tilt. The most material events are the AIG insider sales (over $18M) and Berkshire insider purchases (over $1.5M), signaling divergent management conviction. Capital allocation trends are mixed, with Robinhood's 10b5-1 sales and AIG's executive sales suggesting profit-taking, while Berkshire's purchases indicate confidence. The sector shows a theme of passive investment and ETF adoption, with several 13F filings dominated by large-cap U.S. equities and fixed-income ETFs. Forward-looking data is sparse, but the scheduled events and ongoing 10b5-1 plans warrant monitoring. Overall, the digest highlights a cautious but not bearish sentiment, with selective insider buying and routine regulatory filings dominating the landscape.

6 high priority 7 medium 13 total filings
· daily

S&P 500 Energy Sector SEC Filings — August 13, 2026

The four filings in this digest, all from S&P 500 Energy constituents, reveal a notable pattern of insider selling among senior executives, particularly in the refining and new energies segments. Phillips 66's EVP of Refining, Richard Harbison, sold $11.7M of stock after exercising options, while Chevron's President of New Energies, Jeff Gustavson, sold $2.74M following option exercises. These transactions suggest a potential lack of near-term confidence or a desire to lock in gains at current price levels. Texas Pacific Land saw a minimal insider buy from a 10% owner, which is not material. Chevron's 13F-HR filing showed zero reportable holdings, which is unusual and may indicate a reporting placeholder or a strategic shift in its investment portfolio. The overall sentiment is mixed, with insider selling dominating the signals, but no fundamental operational or financial data was provided to assess broader trends. Investors should monitor these insider activities and any upcoming earnings calls for further guidance.

3 high priority 1 medium 4 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — August 13, 2026

The 8 filings in this Consumer Staples digest are dominated by routine insider transactions and proxy materials, with no major earnings or M&A announcements. The most notable development is AQR Capital Management's 6.34% passive stake in Molson Coors, signaling institutional interest in the beverage sector. General Mills' proxy reveals a 12.2% CEO pay increase despite a stock price decline, raising governance questions. Walmart insiders engaged in tax-related share withholdings, a routine but notable activity. Hershey's president received a stock award, indicating retention efforts. No period-over-period financial comparisons or forward-looking guidance were provided in these filings, limiting trend analysis. The overall sentiment is neutral, with no significant bullish or bearish signals. Investors should monitor upcoming annual meetings and any subsequent insider transactions for further insights.

6 high priority 2 medium 8 total filings
· daily

US Material Events SEC 8-K Filings — August 13, 2026

This Material Events Monitor digest, covering 50 filings from August 13, 2026, reveals a market sharply divided between aggressive capital deployment and acute financial distress. A dominant theme is significant M&A and capital markets activity, led by Parker-Hannifin's $9.25B acquisition of Filtration Group and Global Net Lease's accretive $535M industrial portfolio purchase, signaling confidence in strategic growth. Concurrently, a wave of distressed financing is evident, with companies like Banzai, Lithium Americas, and Professional Diversity Network issuing highly dilutive or complex debt/equity instruments to address liquidity needs. Governance and accounting integrity are under the microscope, highlighted by Pelthos Therapeutics' material weakness restatement and several sudden, unexplained officer departures. While some firms like Opendoor are executing sophisticated, shareholder-friendly capital structure maneuvers, others are facing going-concern risks and auditor changes. The overall picture is one of bifurcation: well-capitalized firms are pursuing transformative deals, while a significant cohort is fighting for survival through complex and often dilutive financing.

50 high priority 50 total filings
· daily

Insider Trading Pulse — August 13, 2026

The insider trading digest for August 13, 2026 reveals a pronounced divergence between insider buying and selling. Buying activity is concentrated in companies like 51Talk, Amrize, and Embecta, where executives are deploying significant capital, often at prices near 52-week lows, signaling strong conviction. Conversely, selling is dominated by Sea Ltd, where multiple C-suite executives, including the CEO, have sold large blocks under Rule 10b5-1 plans, raising concerns about growth sustainability. The data also highlights a cluster of insider purchases in the healthcare and tech sectors, while financials show mixed activity with some notable sales. Period-over-period comparisons, where available, indicate that companies with insider buying are often experiencing revenue growth or margin improvements, while those with selling face margin compression or regulatory headwinds. Overall, the digest suggests selective opportunities in beaten-down names with insider support, but caution around high-flying tech and financial stocks with insider profit-taking.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 13, 2026

The latest batch of 11 filings from Dow 30 constituents reveals a notable pattern of insider selling, particularly at Merck and Chevron, where executives have realized significant gains. While most insider transactions are routine or tax-related, the magnitude of sales at Merck (over $10M by the General Counsel) and Chevron's New Energies President (exercising options and selling) warrants attention. The filings lack forward-looking guidance or period-over-period financial comparisons, limiting trend analysis. However, the insider activity suggests a cautious stance among some executives, potentially signaling near-term valuation concerns. The absence of major capital allocation events (dividends, buybacks) or M&A activity indicates a quiet period for these blue-chip firms. The overall sentiment is mixed, with neutral tax-withholding transactions at Walmart and UnitedHealth offsetting the negative signals from Merck and Chevron. The most critical development is the concentrated insider selling in the healthcare and energy sectors, which could be a leading indicator of sector rotation or profit-taking at perceived highs.

9 high priority 2 medium 11 total filings
· daily

Global High-Priority Regulatory Events — August 13, 2026

This digest covers 50 regulatory filings from August 13, 2026, dominated by distress and restructuring in Indian markets, alongside significant M&A activity in the US. Key themes include a wave of insolvencies (Cerebra, RCOM, Premier, Quadrant, Baron Infotech) and going-concern uncertainties (SAB Events, Leel Electricals), signaling a stressed credit environment. On the M&A front, two mega-deals closed: Parker-Hannifin's $9.25B acquisition of Filtration Group and Global Net Lease's $535M acquisition of Modiv Industrial, both immediately accretive. Insider activity was sparse, but notable was a promoter group entity increasing its stake in OBCL Limited by ~0.75% via open market purchases. Forward-looking statements highlight a catalyst-rich period, with several NCLT hearings and shareholder meetings scheduled in September 2026. The overall sentiment is bearish for distressed Indian entities and cautiously bullish for US industrial consolidation plays.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 13, 2026

The August 13, 2026 SEC filing batch reveals a market bifurcated between operational improvements and persistent financial stress. While several companies (Liftoff Mobile, Global Water Resources, Nuveen Global Cities REIT) posted strong YoY revenue and earnings growth, others (King Resources, Provectus Biopharmaceuticals) continue to burn cash with widening losses. Institutional 13F filings show a pronounced rotation into mega-cap tech and AI-related names, with notable new positions in Arm Holdings and Climb Bio, while hedge funds like Saba Capital trimmed passive stakes. Capital allocation trends highlight aggressive share repurchases at Nuveen Global Cities REIT despite net redemptions, and a shift toward debt-funded growth at Star Mountain. Insider activity is sparse, but the reduction in AQR's stake in Ultragenyx and Saba's cut in Voya Asia Pacific signal cautious sentiment. Forward-looking catalysts include upcoming earnings calls and potential FDA decisions, with the market closely watching guidance revisions and liquidity positions.

16 high priority 34 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 13, 2026

The four filings from S&P 500 Consumer Discretionary constituents reveal a mixed sector picture, with insider activity and capital allocation providing the most actionable signals. A notable divergence in management sentiment is evident: Booking Holdings' CFO executed a significant, pre-planned stock sale of ~$1.79M, a bearish signal from a key insider, while Aptiv's CEO made a large gift of 51,190 shares, which is neutral but reduces his direct stake. Marriott's 8-K filing was a procedural placeholder with no material event, offering no new investment signal. In contrast, Ford Motor Credit's $2.5B debt offering strengthens liquidity but adds fixed interest costs, a neutral development for the parent company's financial health. No period-over-period trends or forward-looking guidance were disclosed in these filings, limiting trend analysis. The key takeaway is a cautious insider posture at Booking Holdings, which warrants monitoring, while Ford's capital markets activity signals a focus on funding operations through debt.

2 high priority 2 medium 4 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 13, 2026

The S&P 500 Healthcare sector is showing a clear pattern of insider selling, with four senior executives from Thermo Fisher Scientific, Merck & Co., Abbott Laboratories, and Amgen collectively liquidating over $21 million in stock. This concentrated selling, often executed under 10b5-1 plans or following option exercises, suggests a period of profit-taking or portfolio rebalancing rather than outright alarm, but the volume and breadth warrant attention. The only positive institutional signal comes from Vanguard's increased passive stake in CVS Health, rising to 9.6% from 9.3% year-over-year, indicating continued index-driven accumulation. No forward-looking guidance, period-over-period financial comparisons, or capital allocation changes were reported in these filings, limiting the ability to assess operational trends. The lack of bullish insider activity and the absence of any buyback or dividend announcements create a cautious near-term outlook for the sector. Investors should monitor upcoming earnings calls for any management commentary that could explain the selling patterns.

6 high priority 2 medium 8 total filings
· daily

US Earnings Financial Results SEC Filings — August 13, 2026

The 50 filings for the period ending August 13, 2026, reveal a market bifurcated between a handful of high-growth, capital-intensive companies executing major IPOs and a broad base of micro-cap firms struggling with cash burn, revenue declines, and widening losses. Key period-over-period trends show a stark contrast: revenue growth at companies like X-Energy (+132% YoY) and Jones Soda (+108% YoY) is driven by new product lines and government contracts, while others like Classover Holdings (-34% YoY) and King Resources (revenue to zero) face severe top-line contraction. A critical portfolio-level pattern is the aggressive use of equity financing—Elmet Group and X-Energy raised a combined $1.2B through IPOs, while several others (Energous, Provectus) relied on at-the-market offerings and convertible notes to stay afloat. Margin compression is a dominant theme, with Energous Corp's gross margin collapsing from 35% to 3% and Elmet Group swinging from a $3.2M operating profit to a $7.6M loss, driven by stock-based compensation and rising G&A. Insider activity is sparse but notable, with several CEOs holding significant positions and no major insider selling detected, suggesting management conviction despite operational challenges. The most critical development is the successful IPOs of X-Energy and Elmet Group, which have transformed their balance sheets and positioned them for aggressive growth, while the persistent cash burn at companies like Global-Smart.Tech (cash down 99% to $81) and Alexander Tech (zero revenue, reliant on related-party loans) signals imminent distress.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 13, 2026

This digest of 8 proxy filings reveals a mixed landscape for executive compensation and governance. While General Mills shows a 12.2% CEO pay increase amid a stock price decline, Culp Inc. demonstrates compensation restraint with a continued base salary freeze for executives. The filings are dominated by routine governance matters, including director elections, auditor ratifications, and say-on-pay votes, with limited period-over-period financial data. A notable trend is the prevalence of virtual-only annual meetings and staggered board structures, particularly in smaller-cap companies like Remora Capital and urban-gro. SideChannel's proposal to drastically reduce authorized shares stands out as a significant capital structure event, while Old Westbury Funds and Worthington Enterprises present standard governance updates. The lack of robust financial performance data in most filings limits deep trend analysis, but the compensation patterns and governance proposals offer actionable insights for investors focused on shareholder rights and management alignment.

8 high priority 8 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 13, 2026

The IPO Pipeline stream for August 13, 2026, features two distinct capital markets events: Rocket Lab's transformative S-4 merger with Iridium Communications and BayFirst Financial's S-1 resale registration. Rocket Lab's acquisition is a high-materiality strategic consolidation, creating a vertically integrated space company with a global satellite network, while BayFirst's filing is a routine resale registration with no new capital raised. Both filings signal active capital markets activity, with Rocket Lab's deal representing a significant catalyst for the space sector and BayFirst's registration indicating potential overhang from a recent private placement. The absence of traditional IPO pricing data in these filings limits period-over-period trend analysis, but the strategic and structural details provide actionable insights for investors.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — August 13, 2026

The August 13, 2026, executive and director change filings reveal a market characterized by significant leadership churn in the biotech and financial services sectors, with a notable number of departures lacking clear succession plans or stated reasons. A key theme is the use of performance-based compensation to retain top talent, as seen with Agenus and OnKure, while several companies like Zenas BioPharma and Marqeta face leadership vacuums that introduce operational uncertainty. The most critical development is the CFO transition at Zenas BioPharma, which coincides with a pivotal FDA PDUFA date for its lead drug, creating a high-stakes situation. Across the filings, the lack of transparency in many officer changes (e.g., Marqeta, BNY Mellon) is a recurring governance concern, while the appointment of high-profile directors at Sprinklr and Welsbach Technology Metals signals strategic pivots toward AI and defense logistics. Overall, the digest points to a bifurcated market where companies with clear succession plans and strong insider alignment are better positioned than those with abrupt departures and opaque disclosures.

23 high priority 23 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 13, 2026

The August 13, 2026 batch of 23 SEC filings reveals a heavy concentration of routine governance changes, but several high-signal events stand out. The most critical development is Zenas BioPharma's CFO transition and its pivotal PDUFA date for obexelimab, creating a binary catalyst. A clear pattern of insider confidence is emerging: Agenus CEO Garo Armen accepted a high-performance stock option award with a 3x-8x strike price premium, signaling strong conviction, while OnKure Therapeutics repriced underwater options to retain talent, indicating internal pressure. Conversely, the sudden departures of Marqeta's CFO and GrabAGun's CEO without named successors or stated reasons are significant governance red flags. Across the board, the biotech sector shows a bifurcation between well-capitalized firms with clear catalysts (Zenas, Olema) and those with opaque leadership changes (Adial, Omeros). The appointment of a top AI executive from Microsoft to Sprinklr's board is a notable strategic hire, while the CFO-to-CEO transition at Magnolia Bancorp raises concerns about leadership depth at a small financial institution. Overall, the digest points to a market where strong insider alignment and clear strategic hires are rewarded, while sudden departures and lack of succession planning create material uncertainty.

23 high priority 23 total filings